|
1
|
Kang KJ and Ahn KS: Anatomical resection
of hepatocellular carcinoma: A critical review of the procedure and
its benefits on survival. World J Gastroenterol. 23:1139–1146.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoffmann K, Franz C, Xiao Z, Mohr E, Serba
S, Büchler MW and Schemmer P: Sorafenib modulates the gene
expression of multi-drug resistance mediating ATP-binding cassette
proteins in experimental hepatocellular carcinoma. Anticancer Res.
30:4503–4508. 2010.PubMed/NCBI
|
|
5
|
Hoffmann K, Müller-Bütow V, Franz C, Hinz
U, Longerich T, Büchler MW and Schemmer P: Factors predictive of
survival after stapler hepatectomy of hepatocellular carcinoma: A
multivariate, single-center analysis. Anticancer Res. 34:767–776.
2014.PubMed/NCBI
|
|
6
|
Lin S, Hoffmann K and Schemmer P:
Treatment of hepatocellular carcinoma: A systematic review. Liver
Cancer. 1:144–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoffmann K, Hinz U, Hillebrand N, Radeleff
BA, Ganten TM, Schirmacher P, Schmidt J, Büchler MW and Schemmer P:
Risk factors of survival after liver transplantation for HCC: A
multivariate single-center analysis. Clin Transplant. 25:E541–E551.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clark HP, Carson WF, Kavanagh PV, Ho CP,
Shen P and Zagoria RJ: Staging and current treatment of
hepatocellular carcinoma. Radiographics. 25 Suppl 1:S3–S23. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schemmer P, Friess H, Hinz U, Mehrabi A,
Kraus TW, Zgraggen K, Schmidt J, Uhl W and Büchler MW: Stapler
hepatectomy is a safe dissection technique: Analysis of 300
patients. World J Surg. 30:419–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scaggiante B, Kazemi M, Pozzato G, Dapas
B, Farra R, Grassi M, Zanconati F and Grassi G: Novel
hepatocellular carcinoma molecules with prognostic and therapeutic
potentials. World J Gastroenterol. 20:1268–1288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neumann O, Kesselmeier M, Geffers R,
Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P,
Schirmacher P, Bermejo J Lorenzo, et al: Methylome analysis and
integrative profiling of human HCCs identify novel protumorigenic
factors. Hepatology. 56:1817–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang B, Jia C, Huang Y, He H, Li J, Liao
H, Liu X, Liu X, Bai X and Yang D: TPX2 level correlates with
hepatocellular carcinoma cell proliferation, apoptosis, and EMT.
Dig Dis Sci. 60:2360–2372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fletcher GC, Patel S, Tyson K, Adam PJ,
Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, et
al: hAG-2 and hAG-3, human homologues of genes involved in
differentiation, are associated with oestrogen receptor-positive
breast tumours and interact with metastasis gene C4.4a and
dystroglycan. Br J Cancer. 88:579–585. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jacobsen B, Santoni-Rugiu E, Illemann M,
Kriegbaum MC, Laerum OD and Ploug M: Expression of C4.4A in
precursor lesions of pulmonary adenocarcinoma and squamous cell
carcinoma. Int J Cancer. 130:2734–2739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paret C, Hildebrand D, Weitz J,
Kopp-Schneider A, Kuhn A, Beer A, Hautmann R and Zöller M: C4.4A as
a candidate marker in the diagnosis of colorectal cancer. Br J
Cancer. 97:1146–1156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hansen LV, Skov BG, Ploug M and Pappot H:
Tumour cell expression of C4.4A, a structural homologue of the
urokinase receptor, correlates with poor prognosis in non-small
cell lung cancer. Lung Cancer. 58:260–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Konishi K, Yamamoto H, Mimori K, Takemasa
I, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Takao T, Doki Y,
et al: Expression of C4.4A at the invasive front is a novel
prognostic marker for disease recurrence of colorectal cancer.
Cancer Sci. 101:2269–2277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oshiro R, Yamamoto H, Takahashi H, Ohtsuka
M, Wu X, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Sekimoto M,
et al: C4.4A is associated with tumor budding and
epithelial-mesenchymal transition of colorectal cancer. Cancer Sci.
103:1155–1164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ngora H, Galli UM, Miyazaki K and Zöller
M: Membrane-bound and exosomal metastasis-associated C4.4A promotes
migration by associating with the α6β4
integrin and MT1-MMP. Neoplasia. 14:95–107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rösel M, Claas C, Seiter S, Herlevsen M
and Zöller M: Cloning and functional characterization of a new
phosphatidyl-inositol anchored molecule of a metastasizing rat
pancreatic tumor. Oncogene. 17:1989–2002. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kriegbaum MC, Jacobsen B, Füchtbauer A,
Hansen GH, Christensen IJ, Rundsten CF, Persson M, Engelholm LH,
Madsen AN, Di Meo I, et al: C4.4A gene ablation is compatible with
normal epidermal development and causes modest overt phenotypes.
Sci Rep. 6:258332016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kriegbaum MC, Jacobsen B, Hald A and Ploug
M: Expression of C4.4A, a structural uPAR homolog, reflects
squamous epithelial differentiation in the adult mouse and during
embryogenesis. J Histochem Cytochem. 59:188–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Willuda J, Linden L, Lerchen HG, Kopitz C,
Stelte-Ludwig B, Pena C, Lange C, Golfier S, Kneip C, Carrigan PE,
et al: Preclinical anti-tumor ffficacy of BAY 1129980-a novel
auristatin-based anti-C4.4A (LYPD3) antibody-drug conjugate for the
treatment of non-small cell lung cancer. Mol Cancer Ther.
16:893–904. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jacobsen B, Kriegbaum MC, Santoni-Rugiu E
and Ploug M: C4.4A as a biomarker in pulmonary adenocarcinoma and
squamous cell carcinoma. World J Clin Oncol. 5:621–632. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu JF, Mao L, Bu LL, Ma SR, Huang CF,
Zhang WF and Sun ZJ: C4.4A as a biomarker of head and neck squamous
cell carcinoma and correlated with epithelial mesenchymal
transition. Am J Cancer Res. 5:3505–3515. 2015.PubMed/NCBI
|
|
28
|
Matzku S, Wenzel A, Liu S and Zöller M:
Antigenic differences between metastatic and nonmetastatic BSp73
rat tumor variants characterized by monoclonal antibodies. Cancer
Res. 49:1294–1299. 1989.PubMed/NCBI
|
|
29
|
Würfel J, Seiter S, Stassar M, Claas A,
Kläs R, Rösel M, Marhaba R, Savelyeva L, Schwab M, Matzku S, et al:
Cloning of the human homologue of the metastasis-associated rat
C4.4A. Gene. 262:35–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hansen LV, Gårdsvoll H, Nielsen BS, Lund
LR, Danø K, Jensen ON and Ploug M: Structural analysis and tissue
localization of human C4.4A: A protein homologue of the urokinase
receptor. Biochem J. 380:845–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thuma F, Ngora H and Zöller M: The
metastasis-associated molecule C4.4A promotes tissue invasion and
anchorage independence by associating with the alpha6beta4
integrin. Mol Oncol. 7:917–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arumugam T, Deng D, Bover L, Wang H,
Logsdon CD and Ramachandran V: New blocking antibodies against
novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic
tumors and increase survival in mice. Mol Cancer Ther. 14:941–951.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong CC, Kai AK and Ng IO: The impact of
hypoxia in hepatocellular carcinoma metastasis. Front Med. 8:33–41.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salnikov AV, Liu L, Platen M, Gladkich J,
Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J,
Schemmer P, et al: Hypoxia induces EMT in low and highly aggressive
pancreatic tumor cells but only cells with cancer stem cell
characteristics acquire pronounced migratory potential. PLoS One.
7:e463912012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu F, Deng X, Yang X, Jin H, Gu D, Lv X,
Wang C, Zhang Y, Huo X, Shen Q, et al: Hypoxia upregulates
Rab11-family interacting protein 4 through HIF-1α to promote the
metastasis of hepatocellular carcinoma. Oncogene. 34:6007–6017.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fries F, Nazarenko I, Hess J, Claas A,
Angel P and Zoller M: CEBPbeta, JunD and c-Jun contribute to the
transcriptional activation of the metastasis-associated C4.4A gene.
Int J Cancer. 120:2135–2147. 2007. View Article : Google Scholar : PubMed/NCBI
|
